Cover Image

Guidance for industry : public health issues posed by the use of nonhuman primate xenografts in humans.

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [1999]
Subjects:	Xenografts > Government policy > United States. Primates > Government policy > United States. Medical policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113609

Similar Items

Guidance for industry : source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans.
Published: (2003)

Guidance for industry : precautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their contacts.
Published: (1999)

Guidance for industry : precautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their intimate contacts.
Published: (2002)

PHS guideline on infectious disease issues in xenotransplantation.
Published: (2001)

Heterografts in primates /
by: Dubernard, Jean-Michel
Published: (1974)

Xenotransplantation : scientific frontiers and public policy /
Published: (1998)

Xenotransplantation : le brevet sur l'animal /
by: Obadia, Alexandra
Published: (2001)

Guidance for industry : independent consultants for biotechnology clinical trial protocols.
Published: (2004)

Xenotransplantation : science, ethics, and public policy /
Published: (1996)

Guidance for industry : use of sterile connecting devices in blood bank practices.
Published: (2000)

Guidance for industry : financial disclosure by clinical investigators.
Published: (2001)

Guidance for industry : testing limits in stability protocols for standardized grass pollen extracts.
Published: (2000)

Guidance for industry : FDA export certificates.
Published: (2005)

Captive Primate Safety Act : report (to accompany H.R. 80) (including cost estimate of the Congressional Budget Office).
Published: (2009)

Guidance for industry and clinical investigators : the use of clinical holds following clinical investigator misconduct.
Published: (2004)

Guidance for industry and FDA staff : early development considerations for innovative combination products.
Published: (2006)

Guidance for industry and FDA staff : devices used to process human cells, tissues, and cellular and tissue-based products (HCT/Ps).
Published: (2007)

Guidance for industry : protecting the rights, safety and welfare of study subjects : supervisory responsibilities of investigators.
Published: (2007)

Guidance for industry : patient-reported outcome measures, use in medical product development to support labeling claims.
Published: (2006)

Guidance for industry : guidance on the labeling of certain uses of Lecithin derived from soy under section 403(w) of the Federal Food, Drug, and Cosmetic Act.
Published: (2006)

Guidance for industry : availability of licensed donor screening tests labeled for use with cadaveric blood specimens.
Published: (2000)

Guidance for industry : guidance for human somatic cell therapy and gene therapy.
Published: (1998)

Guidance for industry : good pharmacovigilance practices and pharmacoepidemiologic assessment.
Published: (2005)

Guidance for industry : formal meetings between the FDA and sponsors or applicants.
Published: (2009)

Guidance for industry : PAT, a framework for innovative pharmaceutical development, manufacturing, and quality assurance.
Published: (2004)

Guidance for industry : notifying FDA of fatalities related to blood collection or transfusion.
Published: (2003)

Guidance for industry : providing regulatory submissions in electronic format, receipt date.
Published: (2007)

Guidance for industry : M4Q, the CTD, quality.
Published: (2001)

Guidance for industry : development and use of risk minimization action plans.
Published: (2005)

60 minutes.
Published: (1998)

Guidance for industry : recommendations for deferral of donors and quarantine and retrieval of blood and blood products in recent recipients of smallpox vaccine (vaccinia virus) and certain contacts of smallpox vaccine recipients.
Published: (2002)

Guidance for industry : clinical studies section of labeling for human prescription drug and biological products, content and format.
Published: (2006)

Captive Primate Safety Act of 2005 : report (to accompany S. 1509).
Published: (2006)

Guidance for industry : submitting and reviewing complete responses to clinical holds.
Published: (2000)

Guidance for industry : format and content for the CMC section of an annual report.
Published: (1994)

Guidance for industry : class II special controls guidance document : cord blood processing system and storage container.
Published: (2007)

Guidance for industry : providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications.
Published: (2008)

Guidance for industry : M4S, the CTD, safety.
Published: (2001)

Guidance for industry : Q3A impurities in new drug substances.
Published: (2008)

Guidance for industry : providing regulatory submissions in electronic format, content of labeling.
Published: (2005)